Yes, provided there is no increased risk for toxicity.
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain:
Jun
25
2022
Yes, provided there is no increased risk for toxicity.
American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain: